Evidence mapPaperPMID 35890791Full record

ReviewSensors (Basel, Switzerland)2022

Recent Developments in the Field of Optical Immunosensors Focusing on a Label-Free, White Light Reflectance Spectroscopy-Based Immunosensing Platform.

Chrysoula-Evangelia Karachaliou, Georgios Koukouvinos, Dimitrios Goustouridis, Ioannis Raptis, Sotirios Kakabakos, Evangelia Livaniou, Panagiota Petrou

Abstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Aflatoxin exposure and health impacts: global burden and advances in detection technologies.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. SERS Immunosensors for Cancer Markers Detection.Materials (Basel, Switzerland) · 2023
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chrysoula-Evangelia KarachaliouImmunopeptide Chemistry Lab, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research ''Demokritos", P.O. Box 60037, 153 10 Agia Paraskevi, Greece.ORCID 0000-0002-0939-9009
Georgios KoukouvinosImmunoassay/Immunosensors Lab, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research ''Demokritos", P.O. Box 60037, 153 10 Agia Paraskevi, Greece.ORCID 0000-0002-2418-1876
Dimitrios GoustouridisThetaMetrisis S.A., 121 32 Athens, Greece.
Ioannis RaptisThetaMetrisis S.A., 121 32 Athens, Greece.
Sotirios KakabakosImmunoassay/Immunosensors Lab, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research ''Demokritos", P.O. Box 60037, 153 10 Agia Paraskevi, Greece.ORCID 0000-0002-0043-3119
Evangelia LivaniouImmunopeptide Chemistry Lab, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research ''Demokritos", P.O. Box 60037, 153 10 Agia Paraskevi, Greece.ORCID 0000-0003-0165-9029
Panagiota PetrouImmunoassay/Immunosensors Lab, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research ''Demokritos", P.O. Box 60037, 153 10 Agia Paraskevi, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical immunosensors represent a research field of continuously increasing interest due to their unique features, which can mainly be attributed to the high-affinity and specific antibodies they use as biorecognition elements, combined with the advantageous characteristics of the optical transducing systems these sensors employ. The present work describes new developments in the field, focusing on recent bioanalytical applications (2021-2022) of labeled and label-free optical immunosensors. Special attention is paid to a specific immunosensing platform based on White Light Reflectance Spectroscopy, in which our labs have gained specific expertise; this platform is presented in detail so as to include developments, improvements, and bioanalytical applications since the mid-2000s. Perspectives on the field are been briefly discussed as well, highlighting the potential of optical immunosensors to eventually reach the state of a reliable, highly versatile, and widely applicable analytical tool suitable for use at the Point-of-Care.

Indexed as

Biosensing TechniquesAntibodiesImmunoassayPoint-of-Care SystemsSpectrum AnalysisAntibodiesanalyteantibodybioanalytical applicationslabeled and label-free immunosensor platformsoptical immunosensorswhite light reflectance spectroscopy

Identifiers

PMID35890791
PMCPMC9325313

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.